TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
ENDRA Life Sciences ( (NDRA) ) just unveiled an announcement.
On October 31, 2025, ENDRA Life Sciences received an extension from Nasdaq to November 24, 2025, to regain compliance with the $2.5 million stockholders’ equity requirement. The company had previously submitted a compliance plan and engaged in financial activities, including a private placement offering and a digital asset purchase, to address the shortfall. As of the latest report, ENDRA believes it has met the equity requirement, but Nasdaq will continue to monitor its compliance, with potential delisting if future reports do not show sustained compliance.
The most recent analyst rating on (NDRA) stock is a Buy with a $38.00 price target. To see the full list of analyst forecasts on ENDRA Life Sciences stock, see the NDRA Stock Forecast page.
Spark’s Take on NDRA Stock
According to Spark, TipRanks’ AI Analyst, NDRA is a Underperform.
ENDRA Life Sciences is currently facing significant financial and operational challenges, with no revenue generation and persistent losses. Despite some short-term technical momentum, the lack of profitability and unattractive valuation metrics weigh heavily on the stock’s potential. Immediate improvements in financial performance and strategic direction are crucial for enhancing its outlook.
To see Spark’s full report on NDRA stock, click here.
More about ENDRA Life Sciences
ENDRA Life Sciences Inc. operates in the medical technology industry, focusing on developing and commercializing imaging solutions for clinical applications. The company is primarily known for its Thermo Acoustic Enhanced Ultrasound (TAEUS) platform, which aims to improve the capabilities of traditional ultrasound systems.
Average Trading Volume: 274,248
Technical Sentiment Signal: Sell
Current Market Cap: $7.3M
For an in-depth examination of NDRA stock, go to TipRanks’ Overview page.